Brind.
  1. Partnership between AstraZeneca and SOPHiA GENETICS SA focuses on AI-powered predictive models for the biopharma sector.

Sophia Genetics announced a multi-year AI breast cancer partnership with AstraZeneca, leveraging its technology for biopharma applications.

1 report, 1 independent Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sophia Genetics announced a multi-year AI breast cancer partnership with AstraZeneca, leveraging its technology for biopharma applications.

Who's involved

What this event is mainly about
Sophia GeneticsAstraZeneca

Keep exploring

Part of

Partnership between AstraZeneca and SOPHiA GENETICS SA focuses on AI-powered predictive models for the biopharma sector. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireSOPHiA GENETICS Reports Second Quarter 2025 Results BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driv